Killed poliovirus antigen titration in humans.
To establish the antigen content of a killed poliovirus vaccine sufficiently potent to induce immunity with one or two doses and to establish a reference standard vaccine which has been tested under field conditions, a titration was carried out in infants to determine the amount of each of the three antigenic types of poliovirus vaccine required to induce seroconversion with a single dose. It has been observed that over a critical range of antigen concentration there is an essentially linear relationship between antibody response and quantity of antigen administered. More than 90 percent of the groups studied had detectable antibody after receiving single injections of 80, 8 and 64 D-antigen units of Types I, II and III, respectively. Four-fold less antigen for each of the three types was less effective. The implications of these findings for an efficient immunization procedure are discussed.
D000914:Antibodies, Viral; D000917:Antibody Formation; D000956:Antigens, Viral / Q000008:administration & dosage*; D006801:Humans; D007109:Immunity; D007223:Infant; D008302:Mali; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage* / Q000276:immunology / Q000592:standards; D013997:Time Factors; D014611:Vaccination
D000914:Antibodies, Viral; D000956:Antigens, Viral; D011054:Poliovirus Vaccine, Inactivated